ID22044A - METHODS AND COMPOUNDS TO INHIBIT BETHA-AMILOID RELEASE PEPTIDES AND OR SYNTHESIS - Google Patents
METHODS AND COMPOUNDS TO INHIBIT BETHA-AMILOID RELEASE PEPTIDES AND OR SYNTHESISInfo
- Publication number
- ID22044A ID22044A IDW990394A ID990394A ID22044A ID 22044 A ID22044 A ID 22044A ID W990394 A IDW990394 A ID W990394A ID 990394 A ID990394 A ID 990394A ID 22044 A ID22044 A ID 22044A
- Authority
- ID
- Indonesia
- Prior art keywords
- amiloid
- betha
- inhibit
- synthesis
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C07K5/06043—Leu-amino acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
- C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75544296A | 1996-11-22 | 1996-11-22 | |
US80852897A | 1997-02-28 | 1997-02-28 | |
US80752897A | 1997-02-28 | 1997-02-28 | |
US80742797A | 1997-02-28 | 1997-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID22044A true ID22044A (en) | 1999-08-26 |
Family
ID=27505670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW990394A ID22044A (en) | 1996-11-22 | 1997-11-21 | METHODS AND COMPOUNDS TO INHIBIT BETHA-AMILOID RELEASE PEPTIDES AND OR SYNTHESIS |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0942924A2 (en) |
JP (1) | JP2001503782A (en) |
KR (1) | KR20000069064A (en) |
CN (1) | CN1238779A (en) |
AR (1) | AR016751A1 (en) |
AU (1) | AU5356198A (en) |
BR (1) | BR9713400A (en) |
CA (1) | CA2267634A1 (en) |
CO (1) | CO4910156A1 (en) |
CZ (1) | CZ122899A3 (en) |
EA (1) | EA199900490A1 (en) |
HR (1) | HRP970627A2 (en) |
HU (1) | HUP0100270A3 (en) |
ID (1) | ID22044A (en) |
IL (1) | IL129083A0 (en) |
NO (1) | NO992368L (en) |
NZ (1) | NZ334690A (en) |
PE (1) | PE16999A1 (en) |
TR (3) | TR199901133T2 (en) |
WO (1) | WO1998022494A2 (en) |
YU (1) | YU46097A (en) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19616486C5 (en) | 1996-04-25 | 2016-06-30 | Royalty Pharma Collection Trust | Method for lowering the blood glucose level in mammals |
US6191166B1 (en) * | 1997-11-21 | 2001-02-20 | Elan Pharmaceuticals, Inc. | Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
US6635632B1 (en) | 1996-12-23 | 2003-10-21 | Athena Neurosciences, Inc. | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
DE19823831A1 (en) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | New pharmaceutical use of isoleucyl thiazolidide and its salts |
US6552013B1 (en) | 1998-06-22 | 2003-04-22 | Elan Pharmaceuticals, Inc. | Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
JP2002518483A (en) * | 1998-06-22 | 2002-06-25 | エラン ファーマシューティカルズ,インコーポレイテッド | Compounds for inhibiting β-amyloid peptide release and / or their synthesis |
JP2002518451A (en) * | 1998-06-22 | 2002-06-25 | エラン ファーマシューティカルズ,インコーポレイテッド | Cyclic amino acid compound and pharmaceutical composition thereof, and method of inhibiting release of β-amyloid peptide and / or synthesis thereof using the compound |
AU4707999A (en) * | 1998-06-22 | 2000-01-10 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
US6958330B1 (en) | 1998-06-22 | 2005-10-25 | Elan Pharmaceuticals, Inc. | Polycyclic α-amino-ε-caprolactams and related compounds |
DE19828113A1 (en) | 1998-06-24 | 2000-01-05 | Probiodrug Ges Fuer Arzneim | Prodrugs of Dipeptidyl Peptidase IV Inhibitors |
DE19828114A1 (en) | 1998-06-24 | 2000-01-27 | Probiodrug Ges Fuer Arzneim | Produgs of unstable inhibitors of dipeptidyl peptidase IV |
DE19834591A1 (en) | 1998-07-31 | 2000-02-03 | Probiodrug Ges Fuer Arzneim | Use of substances that decrease the activity of dipeptidyl peptidase IV to increase blood sugar levels, e.g. for treating hypoglycemia |
US6486350B1 (en) | 1998-09-30 | 2002-11-26 | Elan Pharmaceuticals Inc. | Biological reagents and methods for determining the mechanism in the generation of β-amyloid peptide |
US6737038B1 (en) | 1998-11-12 | 2004-05-18 | Bristol-Myers Squibb Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
EP1137661A1 (en) | 1998-12-10 | 2001-10-04 | F. Hoffmann-La Roche Ag | Procollagen c-proteinase inhibitors |
US6972296B2 (en) | 1999-05-07 | 2005-12-06 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
KR100767199B1 (en) * | 1999-05-07 | 2007-10-17 | 엔싸이시브 파마슈티칼즈 인코퍼레이티드 | Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
US6723711B2 (en) | 1999-05-07 | 2004-04-20 | Texas Biotechnology Corporation | Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
DE19926233C1 (en) | 1999-06-10 | 2000-10-19 | Probiodrug Ges Fuer Arzneim | Production of thiazolidine, useful as pharmaceutical intermediate, comprises reacting hexamethylenetetramine with cysteamine |
DE19940130A1 (en) | 1999-08-24 | 2001-03-01 | Probiodrug Ges Fuer Arzneim | New effectors of Dipeptidyl Peptidase IV for topical use |
EP1235789A2 (en) * | 1999-11-09 | 2002-09-04 | Eli Lilly And Company | $g(b)-AMINOACID COMPOUNDS USEFUL FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
BR0109553A (en) | 2000-03-31 | 2003-06-03 | Probiodrug Ag | Method for the improvement of islet signaling in diabetes mellitus and its prevention |
US6878363B2 (en) | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
MXPA02000862A (en) | 2000-06-01 | 2003-07-14 | Bristol Myers Squibb Pharma Co | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Abgr; PROTEIN PRODUCTION. |
FR2832152A1 (en) * | 2001-11-09 | 2003-05-16 | Aventis Pharma Sa | New 2-amino-thiazoline derivatives having inducible NO-synthase inhibiting activity, useful for treating Parkinson's, cerebral disorders, migraines, depression, diabetes |
GB0016681D0 (en) | 2000-07-06 | 2000-08-23 | Merck Sharp & Dohme | Therapeutic compounds |
US6432944B1 (en) | 2000-07-06 | 2002-08-13 | Bristol-Myers Squibb Company | Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives |
US7132104B1 (en) | 2000-10-27 | 2006-11-07 | Probiodrug Ag | Modulation of central nervous system (CNS) dipeptidyl peptidase IV (DPIV) -like activity for the treatment of neurological and neuropsychological disorders |
US6890905B2 (en) | 2001-04-02 | 2005-05-10 | Prosidion Limited | Methods for improving islet signaling in diabetes mellitus and for its prevention |
US20030130199A1 (en) | 2001-06-27 | 2003-07-10 | Von Hoersten Stephan | Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents |
US7368421B2 (en) | 2001-06-27 | 2008-05-06 | Probiodrug Ag | Use of dipeptidyl peptidase IV inhibitors in the treatment of multiple sclerosis |
DE10150203A1 (en) | 2001-10-12 | 2003-04-17 | Probiodrug Ag | Use of dipeptidyl peptidase IV inhibitor in treatment of cancer |
FR2840899B1 (en) * | 2002-06-12 | 2005-02-25 | Sanofi Synthelabo | ACYLAMINOTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN THERAPEUTICS |
AR039059A1 (en) | 2001-08-06 | 2005-02-09 | Sanofi Aventis | COMPOUND DERIVED FROM ACILAMINOTIAZOL, ITS USE, PROCEDURES TO PREPARE IT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, AND INTERMEDIARY COMPOUNDS |
DE10143840A1 (en) * | 2001-09-06 | 2003-03-27 | Probiodrug Ag | New acylated hydroxamates useful for the treatment of e.g. wound healing |
US6844316B2 (en) | 2001-09-06 | 2005-01-18 | Probiodrug Ag | Inhibitors of dipeptidyl peptidase I |
DE60209806T2 (en) | 2001-11-09 | 2006-11-02 | Aventis Pharma S.A. | 2-AMINO-THIAZOLINE DERIVATIVES AND THEIR USE AS INDUCIBLE NO-SYNTHASE INHIBITORS |
DE20220238U1 (en) | 2002-02-28 | 2003-05-08 | Probiodrug Ag | Glutaminyl based DPIV inhibitors |
AU2004204760C1 (en) * | 2003-01-08 | 2010-08-19 | Novartis Vaccines And Diagnostics, Inc. | Antibacterial agents |
DK2206496T3 (en) | 2003-05-05 | 2014-12-15 | Probiodrug Ag | Screening of inhibitors of pyroglutamic acid formation in amyloid beta peptide |
EP1620091B1 (en) | 2003-05-05 | 2010-03-31 | Probiodrug AG | Inhibitors of glutaminyl cyclase |
WO2005027969A1 (en) * | 2003-09-24 | 2005-03-31 | Santen Pharmaceutical Co., Ltd. | Remedy for eye diseases accompanied by optic nerve injuries |
JP5707014B2 (en) | 2003-10-15 | 2015-04-22 | プロビオドルグ エージー | Use of glutaminyl and glutamate cyclase effectors |
EP2170814B1 (en) | 2007-06-12 | 2016-08-17 | Achaogen, Inc. | Antibacterial agents |
EP2062909A1 (en) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Peptide production and purification process |
BG110141A (en) | 2008-05-23 | 2009-12-31 | "Софарма" Ад | Galanthamine derivatives, methods for their obtaining and use |
WO2013170165A1 (en) | 2012-05-10 | 2013-11-14 | Achaogen, Inc. | Antibacterial agents |
WO2017004560A1 (en) * | 2015-07-02 | 2017-01-05 | The Regents Of The University Of California | Methods and compositions for amyloid aggregates |
WO2022150314A1 (en) * | 2021-01-05 | 2022-07-14 | Southern Research Institute | Modulators of programmed death-ligand-1 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU661270B2 (en) * | 1990-03-05 | 1995-07-20 | Cephalon, Inc. | Chymotrypsin-like proteases and their inhibitors |
WO1995013084A1 (en) * | 1992-05-11 | 1995-05-18 | Miles Inc. | Cathepsin d is an amyloidogenic protease in alzheimer's disease |
ZA945719B (en) * | 1993-08-09 | 1996-02-01 | Lilly Co Eli | Identification and use of protease inhibitors |
CN1078886C (en) * | 1993-10-01 | 2002-02-06 | 默里尔药物公司 | Inhibitor of inhibiting generation of beta-amyloid |
US5804560A (en) * | 1995-01-06 | 1998-09-08 | Sibia Neurosciences, Inc. | Peptide and peptide analog protease inhibitors |
US6017887A (en) * | 1995-01-06 | 2000-01-25 | Sibia Neurosciences, Inc. | Peptide, peptide analog and amino acid analog protease inhibitors |
WO1996039194A1 (en) * | 1995-06-06 | 1996-12-12 | Athena Neurosciences, Inc. | Novel cathepsin and methods and compositions for inhibition thereof |
-
1997
- 1997-11-18 AR ARP970105393A patent/AR016751A1/en not_active Application Discontinuation
- 1997-11-19 HR HR08/808,528A patent/HRP970627A2/en not_active Application Discontinuation
- 1997-11-20 PE PE1997001056A patent/PE16999A1/en not_active Application Discontinuation
- 1997-11-21 CN CN97199803A patent/CN1238779A/en active Pending
- 1997-11-21 KR KR1019997004486A patent/KR20000069064A/en not_active Application Discontinuation
- 1997-11-21 YU YU46097A patent/YU46097A/en unknown
- 1997-11-21 CO CO97068215A patent/CO4910156A1/en unknown
- 1997-11-21 CZ CZ991228A patent/CZ122899A3/en unknown
- 1997-11-21 CA CA002267634A patent/CA2267634A1/en not_active Abandoned
- 1997-11-21 NZ NZ334690A patent/NZ334690A/en unknown
- 1997-11-21 TR TR1999/01133T patent/TR199901133T2/en unknown
- 1997-11-21 WO PCT/US1997/020804 patent/WO1998022494A2/en not_active Application Discontinuation
- 1997-11-21 HU HU0100270A patent/HUP0100270A3/en unknown
- 1997-11-21 EA EA199900490A patent/EA199900490A1/en unknown
- 1997-11-21 TR TR1999/02937T patent/TR199902937T2/en unknown
- 1997-11-21 TR TR1999/02938T patent/TR199902938T2/en unknown
- 1997-11-21 AU AU53561/98A patent/AU5356198A/en not_active Abandoned
- 1997-11-21 BR BR9713400-7A patent/BR9713400A/en not_active IP Right Cessation
- 1997-11-21 JP JP52375698A patent/JP2001503782A/en active Pending
- 1997-11-21 ID IDW990394A patent/ID22044A/en unknown
- 1997-11-21 IL IL12908397A patent/IL129083A0/en unknown
- 1997-11-21 EP EP97950601A patent/EP0942924A2/en not_active Withdrawn
-
1999
- 1999-05-14 NO NO992368A patent/NO992368L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
YU46097A (en) | 2000-10-30 |
EA199900490A1 (en) | 2000-02-28 |
IL129083A0 (en) | 2000-02-17 |
CN1238779A (en) | 1999-12-15 |
HRP970627A2 (en) | 1998-08-31 |
CA2267634A1 (en) | 1998-05-28 |
HUP0100270A3 (en) | 2001-09-28 |
JP2001503782A (en) | 2001-03-21 |
NZ334690A (en) | 2001-09-28 |
EP0942924A2 (en) | 1999-09-22 |
KR20000069064A (en) | 2000-11-25 |
BR9713400A (en) | 2000-01-25 |
NO992368D0 (en) | 1999-05-14 |
TR199901133T2 (en) | 1999-07-21 |
HUP0100270A2 (en) | 2001-08-28 |
AU5356198A (en) | 1998-06-10 |
NO992368L (en) | 1999-06-21 |
WO1998022494A2 (en) | 1998-05-28 |
WO1998022494A3 (en) | 1998-11-26 |
TR199902937T2 (en) | 2001-01-22 |
PE16999A1 (en) | 1999-02-19 |
TR199902938T2 (en) | 2002-06-21 |
CZ122899A3 (en) | 1999-10-13 |
CO4910156A1 (en) | 2000-04-24 |
AR016751A1 (en) | 2001-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID22044A (en) | METHODS AND COMPOUNDS TO INHIBIT BETHA-AMILOID RELEASE PEPTIDES AND OR SYNTHESIS | |
ID19422A (en) | PYRIDINA AND SUBSTITUTED BIFENYL | |
DE69701836T2 (en) | Fastener | |
ID19769A (en) | SYNTHESIS OF CHEMICAL AND ISOPRENOID USES | |
ID17323A (en) | METHODS AND SYSTEMS FOR SYNTHESIS OF OLIGONUKLEOTIDE-OLIGONUKLEOTIDE USING NUCLEOTIDE-FREE STONES | |
ID16889A (en) | ALKILAMINOBENZOTIAZOL AND BENZOKSAZOL COMPOUNDS | |
NO983743D0 (en) | anchoring System | |
ID18456A (en) | PRODUCTION-JOINT 6-AMINOCAPRONITRIL AND HEXSAMETYLENADIAMINA | |
ID20134A (en) | UREA SYNTHESIS AND IMPROVED UREA SYNTHESIS | |
DE59711717D1 (en) | fastener | |
ID18459A (en) | PRODUCTION-JOINT 6-AMINOCAPRONITRIL AND HEXSAMETYLENADIAMINA | |
ID16587A (en) | 6-AMINOCAPRONITRIL AND HEXSAMETYLENDIAMIN COOPRODUCTION | |
DE29607882U1 (en) | Fastener | |
DE29603389U1 (en) | Quick release | |
DE29618959U1 (en) | Fastener | |
BR9710019A (en) | Virginiamycin mixture | |
DE59703427D1 (en) | Fastener | |
DE29720745U1 (en) | Fastener | |
DE29611827U1 (en) | Fastener | |
NO973425D0 (en) | anchor System | |
DE69701674D1 (en) | IMPROVING THE SEAL OF TIED MATS | |
DE29620770U1 (en) | Fastener | |
DE29622205U1 (en) | Fastening unit | |
PT1021384E (en) | REGENERATION OF PLASTER MATERIALS | |
DE29606164U1 (en) | Fastener |